New York, October 8th / PRNewswire / —Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp ("Anavex" or "the Company") (Nasdaq: AVXL). Affected investors may contact Danielle Peyton at [email protected], or by phone at 646-581-9980, or via the toll-free number 888.4- POMLAW ext. 7980. Those consulting by email are advised to attach their mailing address, phone number, and the number of shares purchased.
This class action involves whether Anavex and some of its senior executives and/or directors have engaged in securities fraud or other illegal business practices.
If you purchased or acquired Anavex securities during the class action period, you may request the court to appoint you as the lead plaintiff of the class action before November 30, 2026. Copies of the complaint are available at www.pomerantzlaw.com.
[Click here to learn about joining the class action.]
On May 6, 2026, Anavex reported that the company's board of directors' special committee had "terminated for certain reasons the employment relationship of Dr. Christopher Missling as the company's CEO," and stated that this decision "took effect immediately, with reasons including behaviors that the special committee deemed inconsistent with company policies."
Affected by this news, the stock price of Anavex fell by $0.22 on May 7, 2026, a decrease of 6.59%, closing at $3.12 per share.
Subsequently, on August 28, 2026, Anavex submitted to the U.S. Securities and Exchange Commission its revised annual report for the fiscal year ending September 30, 2025, Form 10-K/A ("2025 Revised Annual Report"), which disclosed that management deemed that "as of September 30, 2025, there were significant deficiencies in the company's internal control over financial reporting," and due to these significant deficiencies in internal control over financial reporting, the company's disclosure controls and procedures as of September 30, 2025, were not effective.
Affected by this news, the stock price of Anavex fell by $0.19 on August 31, 2026, a decrease of 6.35%, closing at $2.80 per share.
Pomerantz LLP has offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, and is recognized as one of the leading law firms in the fields of corporate law, securities law, and class action litigation. The firm was founded by the late Abraham L Pomerantz, who is known as the "dean" of the class action litigation community and pioneered the field of securities class actions. More than 85 years later, Pomerantz continues this tradition, fighting for the rights of victims of securities fraud, breach of fiduciary duty, and corporate misconduct. The firm has recovered millions of dollars in compensation on behalf of its class members. For more information, please refer to www.pomlaw.com.
Lawyer advertisement. Past results do not guarantee similar outcomes in the future.
Contact Information:
Danielle Peyton
Pomerantz LLP
[ email protected ]
646-581-9980 ext . 7980
